A Phase 2 Study of GVAX Colon Vaccine (With Cyclophosphamide) and Pembrolizumab in Patients With Mismatch Repair-Proficient (MMR-p) Advanced Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Cyclophosphamide (Primary) ; Pembrolizumab (Primary) ; Tumour cell vaccine-GVAX (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 25 May 2017 Status changed from not yet recruiting to recruiting.
- 26 Apr 2017 Planned initiation date changed from 1 Mar 2017 to 1 May 2017.
- 07 Dec 2016 New trial record